Joanne Gray


Joanne Gray is co-chair of the firm’s Food and Healthy Living Practice. Ms. Gray’s industry-focused practice concentrates in the consumer products area, including FDA regulated companies in the food and beverage, dietary supplement, pharmaceutical and medical device, and technology industries. She provides compliance advice and handles litigation for clients in these highly regulated industries. Ms. Gray is chair of the firm’s Specialty Litigation Group and its Products Liability + Mass Torts Practice. Her litigation practice involves defending companies in high profile products liability, class actions, consumer fraud and mass tort claims.

In the compliance area, Ms. Gray’s counseling practice involves providing regulatory advice, mergers and acquisition advice and litigation avoidance counseling to companies in FDA regulated industries. She counsels clients on regulatory compliance and provides risk management and strategic advice to a wide range of food and supplement businesses, including in the fast growing and rapidly changing healthy living section of the industry. Ms. Gray is involved in counseling and strategic planning for food, dietary supplements and consumer product launches as well as product recalls, and provides advice on company or product lines acquisitions. She often works with food and supplement companies by providing strategic business and regulatory advice regarding products that incorporate new and evolving technologies or novel ingredients, including providing GMP and audit advice that allows leading companies to develop innovative new products while reducing regulatory risk. Her counseling practice includes public relations and crisis management counseling for these industries.


July 18, 2018

8:30 AM  -  9:40 AM

NBJ State of the Industry

Change in the dietary supplement industry is happening faster than ever, driven by forces that include regulatory developments, health-tracking technologies, ingredient innovation and the accelerating complexity of consumers spreading purchases across sales channels. This session will showcase Nutrition Business Journal’s proprietary market data and survey results to reveal where the market is expanding, where consumers … Continued

Click for more information on 'NBJ State of the Industry'

July 18, 2018

12:00 PM  -  1:00 PM

The Blurring Line Between Big Pharma and Nutraceuticals

The line between nutraceuticals, OTC and pharma is being redefined. Active and engaged on that blurring line, this panel of experts will explore what’s coming and how we might re-envision DSHEA to take the industry where it needs to go to realize the goal of changing healthcare. Defining the right science and how it fits … Continued

Click for more information on 'The Blurring Line Between Big Pharma and Nutraceuticals'